Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Dale Chappell. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Dale Chappell reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:HGEN / Humanigen, Inc. Chief Scientific Officer, Director, 10% Owner 8,398,871
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Dale Chappell. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Dale Chappell conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2023-10-20 2023-10-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -276,210 8,398,871 -3.18 0.01 -3,038 92,388
2023-10-20 2023-10-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -75,887 2,307,530 -3.18 0.01 -835 25,383
2023-10-20 2023-10-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -34,253 1,041,536 -3.18 0.01 -377 11,457
2022-05-20 2022-05-20 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 381,841 8,675,081 4.60 2.23 850,742 19,328,080
2022-05-20 2022-05-20 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 109,098 2,383,417 4.80 2.23 243,070 5,310,253
2022-05-20 2022-05-20 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 54,549 1,075,789 5.34 2.23 121,535 2,396,858
2022-05-20 2022-05-19 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 226,665 8,293,240 2.81 2.19 495,490 18,129,023
2022-05-20 2022-05-19 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 64,762 2,274,319 2.93 2.19 141,570 4,971,661
2022-05-20 2022-05-19 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 32,381 1,021,240 3.27 2.19 70,785 2,232,431
2022-05-20 2022-05-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 121,590 8,066,575 1.53 1.96 238,560 15,826,620
2022-05-20 2022-05-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 34,740 2,209,557 1.60 1.96 68,160 4,335,151
2022-05-20 2022-05-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 17,370 988,859 1.79 1.96 34,080 1,940,141
2022-03-15 2022-03-11 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 700,000 7,944,985 9.66 3.00 2,100,000 23,834,955
2022-03-15 2022-03-11 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 200,000 2,174,817 10.13 3.00 600,000 6,524,451
2022-03-15 2022-03-11 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 100,000 971,489 11.47 3.00 300,000 2,914,467
2022-03-10 2022-03-10 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 550 2,866 23.75 0.75 412 2,150
2022-03-10 2022-03-10 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 157 818 23.75 0.75 118 614
2022-03-10 2022-03-10 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 79 410 23.87 0.75 59 308
2022-03-10 2022-03-09 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 1,026 2,316 79.53 0.79 807 1,823
2022-03-10 2022-03-09 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 36 7,393 0.49 1.20 43 8,872
2022-03-10 2022-03-09 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 293 661 79.62 0.79 231 520
2022-03-10 2022-03-09 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 10 2,111 0.48 1.20 12 2,533
2022-03-10 2022-03-09 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 147 331 79.89 0.79 116 260
2022-03-10 2022-03-09 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 5 1,055 0.48 1.20 6 1,266
2022-03-10 2022-03-08 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 1,668 7,357 29.32 1.20 2,002 8,828
2022-03-10 2022-03-08 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 476 2,101 29.29 1.20 571 2,521
2022-03-10 2022-03-08 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 238 1,050 29.31 1.20 286 1,260
2022-03-04 2022-03-04 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 891 5,689 18.57 0.90 799 5,104
2022-03-04 2022-03-04 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 255 1,625 18.61 0.90 229 1,458
2022-03-04 2022-03-04 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 127 812 18.54 0.90 114 729
2022-03-04 2022-03-03 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 1,213 1,290 1,575.32 0.35 425 452
2022-03-04 2022-03-03 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 36 4,798 0.76 0.70 25 3,359
2022-03-04 2022-03-03 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 346 368 1,572.73 0.35 121 129
2022-03-04 2022-03-03 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 10 1,370 0.74 0.70 7 959
2022-03-04 2022-03-03 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 173 184 1,572.73 0.35 61 64
2022-03-04 2022-03-03 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 5 685 0.74 0.70 4 480
2022-03-04 2022-03-02 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 77 77 0.33 25 25
2022-03-04 2022-03-02 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 4,762 4,762 0.60 2,838 2,838
2022-03-04 2022-03-02 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 22 22 0.33 7 7
2022-03-04 2022-03-02 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 1,360 1,360 0.60 811 811
2022-03-04 2022-03-02 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 11 11 0.33 4 4
2022-03-04 2022-03-02 4 HGEN HUMANIGEN, INC
Call Option (Right to Buy)
P - Purchase 680 680 0.60 405 405
2022-01-14 2022-01-12 4 HGEN HUMANIGEN, INC
Stock Option (Right to Buy)
A - Award 36,550 36,550
2022-01-04 2021-12-31 4 HGEN HUMANIGEN, INC
Stock Option (Right to Buy)
A - Award 44,600 44,600
2021-10-04 2021-09-30 4 HGEN HUMANIGEN, INC
Stock Option (Right to Buy)
A - Award 22,626 22,626
2021-08-13 2021-08-12 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -41,725 7,266,296 -0.57 17.16 -715,993 124,688,186
2021-08-13 2021-08-12 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -11,510 1,980,696 -0.58 17.16 -197,509 33,988,347
2021-08-13 2021-08-12 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -4,316 873,693 -0.49 17.16 -74,062 14,992,397
2021-08-13 2021-08-11 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -79,494 7,308,021 -1.08 17.07 -1,357,304 124,779,343
2021-08-13 2021-08-11 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -21,929 1,992,206 -1.09 17.07 -374,422 34,015,523
2021-08-13 2021-08-11 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -8,224 878,009 -0.93 17.07 -140,419 14,991,389
2021-07-30 2021-07-29 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -21,311 7,366,204 -0.29 17.03 -363,016 125,477,392
2021-07-30 2021-07-29 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -5,879 2,008,256 -0.29 17.03 -100,144 34,209,034
2021-07-30 2021-07-29 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -2,204 884,029 -0.25 17.03 -37,543 15,058,727
2021-07-30 2021-07-28 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -7,027 7,387,515 -0.10 17.04 -119,748 125,891,382
2021-07-30 2021-07-28 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -1,938 2,014,135 -0.10 17.04 -33,026 34,323,076
2021-07-30 2021-07-28 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -727 886,233 -0.08 17.04 -12,389 15,102,385
2021-07-23 2021-07-23 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -4,048 7,394,542 -0.05 17.04 -68,980 126,007,432
2021-07-23 2021-07-23 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -1,117 2,016,073 -0.06 17.04 -19,034 34,355,094
2021-07-23 2021-07-23 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -419 886,960 -0.05 17.04 -7,140 15,114,331
2021-07-23 2021-07-22 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -129,054 7,398,590 -1.71 17.04 -2,198,783 126,054,957
2021-07-23 2021-07-22 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -35,601 2,017,190 -1.73 17.04 -606,559 34,368,278
2021-07-23 2021-07-22 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -13,350 887,379 -1.48 17.04 -227,453 15,118,897
2021-07-23 2021-07-21 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -96,254 7,527,644 -1.26 17.14 -1,649,466 128,998,224
2021-07-23 2021-07-21 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -26,553 2,052,791 -1.28 17.14 -455,028 35,177,858
2021-07-23 2021-07-21 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -9,957 900,729 -1.09 17.14 -170,629 15,435,433
2021-07-16 2021-07-14 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -11,003 7,623,898 -0.14 17.06 -187,658 130,027,105
2021-07-16 2021-07-14 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -3,036 2,079,344 -0.15 17.06 -51,780 35,463,628
2021-07-16 2021-07-14 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -1,138 910,686 -0.12 17.06 -19,409 15,531,932
2021-07-09 2021-07-09 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -214,626 7,634,901 -2.73 17.37 -3,728,504 132,634,264
2021-07-09 2021-07-09 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -59,207 2,082,380 -2.76 17.37 -1,028,550 36,175,314
2021-07-09 2021-07-09 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -22,203 911,824 -2.38 17.37 -385,713 15,840,298
2021-07-09 2021-07-08 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -34,807 7,849,527 -0.44 17.17 -597,476 134,740,271
2021-07-09 2021-07-08 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -9,602 2,141,587 -0.45 17.17 -164,822 36,761,197
2021-07-09 2021-07-08 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -3,601 934,027 -0.38 17.17 -61,813 16,032,947
2021-07-02 2021-07-02 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -74,565 7,884,334 -0.94 17.12 -1,276,553 134,979,798
2021-07-02 2021-07-02 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -20,569 2,151,189 -0.95 17.12 -352,141 36,828,356
2021-07-02 2021-07-02 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -7,714 937,628 -0.82 17.12 -132,064 16,052,191
2021-07-02 2021-07-01 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -102,219 7,958,899 -1.27 17.10 -1,747,730 136,080,459
2021-07-02 2021-07-01 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -28,198 2,171,758 -1.28 17.10 -482,127 37,132,501
2021-07-02 2021-07-01 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -10,575 945,342 -1.11 17.10 -180,810 16,163,363
2021-07-02 2021-06-30 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -158,961 8,061,118 -1.93 17.28 -2,746,274 139,267,099
2021-07-02 2021-06-30 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -43,851 2,199,956 -1.95 17.28 -757,587 38,007,320
2021-07-02 2021-06-30 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -16,444 955,917 -1.69 17.28 -284,093 16,514,804
2021-06-25 2021-06-25 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -725,000 8,220,079 -8.11 17.80 -12,907,538 146,346,176
2021-06-25 2021-06-25 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -200,000 2,243,807 -8.18 17.80 -3,560,700 39,947,618
2021-06-25 2021-06-25 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -75,000 972,361 -7.16 17.80 -1,335,262 17,311,429
2021-06-25 2021-06-24 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -101,158 8,945,079 -1.12 18.37 -1,858,768 164,364,932
2021-06-25 2021-06-24 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -27,906 2,443,807 -1.13 18.37 -512,770 44,904,709
2021-06-25 2021-06-24 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -10,465 1,047,361 -0.99 18.37 -192,293 19,245,154
2021-06-25 2021-06-23 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -96,516 9,046,237 -1.06 18.28 -1,764,776 165,408,634
2021-06-25 2021-06-23 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -26,625 2,471,713 -1.07 18.28 -486,833 45,194,778
2021-06-25 2021-06-23 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale X -9,985 1,057,826 -0.94 18.28 -182,574 19,342,137
2021-06-21 2021-06-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -291,798 9,142,753 -3.09 18.50 -5,398,030 169,133,616
2021-06-21 2021-06-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -80,496 2,498,338 -3.12 18.50 -1,489,112 46,217,254
2021-06-21 2021-06-18 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -30,186 1,067,811 -2.75 18.50 -558,417 19,753,649
2021-06-21 2021-06-17 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -131,532 9,434,551 -1.37 19.17 -2,521,876 180,889,590
2021-06-21 2021-06-17 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -36,284 2,578,834 -1.39 19.17 -695,677 49,444,242
2021-06-21 2021-06-17 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -13,607 1,097,997 -1.22 19.17 -260,888 21,052,006
2021-06-21 2021-06-16 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -111,325 9,566,083 -1.15 19.40 -2,160,061 185,612,622
2021-06-21 2021-06-16 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -34,431 2,615,118 -1.30 19.40 -667,948 50,732,243
2021-06-21 2021-06-16 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -12,730 1,111,604 -1.13 19.50 -248,178 21,671,276
2021-06-09 2021-06-07 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -42,440 9,677,408 -0.44 19.08 -809,891 184,675,912
2021-06-09 2021-06-07 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -25,464 2,649,549 -0.95 19.08 -485,935 50,561,873
2021-06-09 2021-06-07 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -12,732 1,124,334 -1.12 19.08 -242,967 21,455,891
2021-06-04 2021-06-04 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -66,886 9,719,848 -0.68 18.46 -1,234,950 179,462,414
2021-06-04 2021-06-04 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -40,132 2,675,013 -1.48 18.46 -740,977 49,390,103
2021-06-04 2021-06-04 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -20,066 1,137,066 -1.73 18.46 -370,489 20,994,218
2021-06-04 2021-06-03 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -100,607 9,786,734 -1.02 18.37 -1,848,050 179,772,517
2021-06-04 2021-06-03 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -60,365 2,715,145 -2.17 18.37 -1,108,845 49,874,499
2021-06-04 2021-06-03 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -30,182 1,157,132 -2.54 18.37 -554,413 21,255,358
2021-06-04 2021-06-02 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -40,042 9,887,341 -0.40 19.01 -761,258 187,973,183
2021-06-04 2021-06-02 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -24,056 2,775,510 -0.86 19.01 -457,341 52,766,608
2021-06-04 2021-06-02 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
S - Sale -12,028 1,187,314 -1.00 19.01 -228,670 22,572,620
2020-09-22 2020-09-18 4 HGEN HUMANIGEN, INC
Stock Option (right to buy)
A - Award 133,760 133,760 9.65 1,290,784 1,290,784
2020-04-07 2020-04-02 4 HGEN HUMANIGEN, INC
Convertible Note
C - Conversion 0 500,000.00
2020-04-07 2020-04-02 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
C - Conversion 1,583,333 49,636,917 3.29 0.36 570,000 17,869,290
2020-04-07 2018-09-20 4 HGEN HUMANIGEN, INC
Convertible Note
J - Other 500,000.00
2019-06-04 2019-05-31 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
J - Other 586,027 48,053,584 1.23
2019-06-04 2019-05-31 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
J - Other 591,248 47,467,557 1.26
2018-03-01 2018-02-27 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
P - Purchase 32,028,669 46,876,309 215.72 0.09 3,001,086 4,392,310
2018-03-01 2018-02-27 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
J - Other 12,812,322 14,847,640 629.50
2018-03-01 2018-02-27 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
J - Other 11,957,369 13,997,832 586.01
2018-03-01 2018-02-27 4 HGEN HUMANIGEN, INC
Common Stock, $0.001 par value
J - Other 5,123,733 5,996,710 586.93
2016-09-15 2016-09-13 4 KBIO KALOBIOS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 100,000 100,000
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
5,821,735
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,989,221
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,984,076
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
5,821,735
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,989,221
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,984,076
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
5,821,735
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,989,221
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,984,076
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
5,821,735
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,989,221
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,984,076
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
5,821,735
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,989,221
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,984,076
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
5,821,735
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,989,221
2016-07-11 3 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock, par value $0.001
6,984,076
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)